New national medical guidelines for the diagnostic evaluation of patients suspected of having AD, FTD, or a related condition
December 23, 2024 We have entered a new era of improved and emerging biologically-based diagnostic biomarkers for Alzheimer’s disease (AD) and AD-related neurodegenerative disorders (ADRD) that [...]